MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK)

Historical Portfolio Holders from Q3 2017 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
391K
Holdings value Q2 2024
$5.32M
Value change Q2 2024
-$132M
Grand Portfolio weight change Q2 2024
0%
Number of holders
5
Number of buys Q2 2024
0
Number of sells Q2 2024
-1
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$4.11K 0
2024 Q2 391K $5.32M -$132M $15.13 5
2024 Q1 9.28M $137M +$447K $14.77 66
2023 Q4 9.31M $125M +$3.43M $13.41 68
2023 Q3 8.47M $104M +$5.75M $12.33 63
2023 Q2 8.01M $98.5M +$7.39M $12.30 61
2023 Q1 7.4M $91M -$942K $12.29 48
2022 Q4 7.55M $86.6M +$3.47M $11.46 44
2022 Q3 8.01M $30M -$1.5M $3.75 35
2022 Q2 8.06M $48M +$942K $5.95 36
2022 Q1 7.9M $49.4M +$2.61M $6.32 39
2021 Q4 7.5M $29.3M -$757K $3.91 32
2021 Q3 7.68M $37.1M -$1.1M $4.83 34
2021 Q2 7.87M $50.3M -$388K $6.39 40
2021 Q1 7.93M $49.8M -$284K $6.28 40
2020 Q4 7.98M $55M +$6.89M $6.89 32
2020 Q3 6.99M $27.7M +$3.25M $4.00 30
2020 Q2 6.16M $20.5M -$917K $3.33 31
2020 Q1 6.46M $13.9M -$1.3M $2.15 30
2019 Q4 6.92M $21.8M +$984K $3.15 41
2019 Q3 6.6M $29.7M -$128K $4.49 38
2019 Q2 6.44M $39M +$8.67M $6.05 45
2019 Q1 5.43M $37.7M +$228K $6.95 48
2018 Q4 6.12M $23.6M -$3.09M $3.86 47
2018 Q3 6.27M $33.4M -$210K $5.33 55
2018 Q2 6.33M $31.1M -$8.74M $4.91 65
2018 Q1 7.59M $61.2M +$3.12M $8.05 72
2017 Q4 7.18M $73.6M +$4.77M $10.25 71
2017 Q3 5.53M $80.4M +$80.4M $14.54 61